ARENA PHARMACEUTICALS
Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases. Their leading drug candidate is lorcaserin hydrochloride, which recently received positive data from a clinical trial. They are headquartered in San Diego, CA.
ARENA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1977-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.arenapharm.com
Total Employee:
251+
Status:
Active
Contact:
858-453-7200
Email Addresses:
[email protected]
Total Funding:
1.06 B USD
Technology used in webpage:
Domain Not Resolving IPv6 Microsoft Typekit Akamai Hosted
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Anthera Pharmaceuticals
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
C-Dragon
C-Dragon is a pharmaceutical manufacturing company.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
West Pharmaceutical Services, Inc
West Pharmaceutical Services, our mission is to develop and apply proprietary technologies that improve the safety and effectiveness.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Arena Pharmaceuticals
Deerfield Capital Management
Deerfield Capital Management investment in Post-IPO Equity - Arena Pharmaceuticals
Deerfield Capital Management
Deerfield Capital Management investment in Post-IPO Equity - Arena Pharmaceuticals
Deerfield
Deerfield investment in Post-IPO Equity - Arena Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-07-27 | Aristea Therapeutics | Arena Pharmaceuticals investment in Series B - Aristea Therapeutics | 63 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-13 | Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary |
Official Site Inspections
http://www.arenapharm.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
More informations about "Arena Pharmaceuticals"
Arena Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number 858-453-7200 Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases.See details»
Pfizer Completes Acquisition of Arena Pharmaceuticals
Mar 11, 2022 Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases Pfizer Inc. …See details»
Pfizer to Acquire Arena Pharmaceuticals | Business Wire
Dec 13, 2021 These documents are available free of charge at the SEC’s web site at www.sec.gov and by going to Arena’s website at https://invest.arenapharm.com. Contacts …See details»
Pfizer to Acquire Arena Pharmaceuticals
Dec 13, 2021 Proposed acquisition offers potentially new, differentiated best-in-class approach to address unmet need for a broader number of patients with immuno-inflammatory diseases …See details»
Arena Pharmaceuticals - Devex
Learn more about Arena Pharmaceuticals's jobs, projects, latest news, contact information and geographical presence. Arena is a biopharmaceutical company focused on developing novel, …See details»
Arena Pharmaceuticals, Inc. | LinkedIn
Arena Pharmaceuticals, Inc. | 25,960 followers on LinkedIn. Arena is now part of Pfizer. | Arena is now part of Pfizer.See details»
Pfizer Inc. - Pfizer to Acquire Arena Pharmaceuticals
Dec 13, 2021 Proposed acquisition offers potentially new, differentiated best-in-class approach to address unmet need for a broader number of patients with immuno-inflammatory diseases …See details»
Arena Pharmaceuticals - Craft
San Diego, CA HQ. United States. 6154 Nancy Ridge Dr. Boston, MA. United States. 1 Beacon St. Park City, UT. United States. 136 Heber Ave #204. Zug, ZG. SwitzerlandSee details»
Arena Pharmaceuticals | ARNA Stock Price, Company Overview
Mar 30, 2022 Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien …See details»
Arena Pharmaceuticals Development GmbH – Swiss Biotech
Arena Pharmaceuticals is driven to deliver novel, transformational medicines with optimized pharmacology and pharmacokinetics to patients globally. Arena's proprietary pipeline includes …See details»
Arena Pharmaceuticals Announces Changes to Board of Directors
Feb 16, 2021 Contacts. Corporate Contact: Patrick Malloy Arena Pharmaceuticals, Inc. Vice President, Investor Relations & Corporate Communications [email protected] …See details»
Pfizer to acquire Arena Pharmaceuticals in $6.7 billion deal
Dec 13, 2021 Pfizer said on Monday it would buy drug developer Arena Pharmaceuticals for $6.7 billion in cash.See details»
Pfizer to Acquire Arena for $6.7B, Expanding Immuno …
Dec 13, 2021 Pfizer has agreed to acquire Arena Pharmaceuticals for approximately $6.7 billion, the companies said today, in a deal designed to expand the buyer’s immuno-inflammatory …See details»
Arena Pharmaceuticals Announces Launch of Longboard ... - Nasdaq
Oct 28, 2020 Arena Corporate Contacts: Patrick Malloy Vice President, Investor Relations & Corporate [email protected] Megan E. Knight …See details»
Arena Pharmaceuticals Releases Second Annual Environmental, …
Apr 19, 2021 Corporate Contact: Patrick Malloy Arena Pharmaceuticals, Inc. Vice President, Investor Relations & Corporate Communications [email protected] 847.987.4878 …See details»
Why Arena Pharmaceuticals Stock Skyrocketed 80% Today
Dec 13, 2021 Pfizer is seeking to purchase all of Arena's outstanding stock for $100 per share, or slightly more than double its closing price on Friday. The all-cash deal values Arena at …See details»
Arena Reports Fourth Quarter and Full Year 2021 Financial Results …
Feb 23, 2022 Patrick Malloy Arena Pharmaceuticals, Inc. Vice President, Investor Relations & Corporate Communications [email protected] 847.987.4878See details»
Arena Pharmaceuticals - Overview, News & Similar companies
Who is Arena Pharmaceuticals. Established early in 2001, Arena Pharmaceuticals specialises in the supply of Active Pharmaceutical Ingredients (APIs) to the pharmaceutical, veter inary and …See details»
Arena Pharmaceuticals to Release Third Quarter 2021 Financial …
Oct 14, 2021 Corporate Contact: Patrick Malloy Arena Pharmaceuticals, Inc. Vice President, Investor Relations & Corporate Communications [email protected] 847.987.4878 …See details»